Provided by Tiger Trade Technology Pte. Ltd.

Serina Therapeutics, Inc.

2.87
+0.22008.30%
Post-market: 2.80-0.0700-2.44%19:30 EDT
Volume:46.11K
Turnover:128.72K
Market Cap:72.90M
PE:-1.49
High:2.87
Open:2.67
Low:2.62
Close:2.65
52wk High:7.92
52wk Low:1.22
Shares:25.40M
Float Shares:12.51M
Volume Ratio:0.52
T/O Rate:0.37%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9304
EPS(LYR):-1.9100
ROE:-207.94%
ROA:-92.30%
PB:3.89
PE(LYR):-1.50

Loading ...

Serina Therapeutics Announces Nyse American Acceptance of Continued Listing Compliance Plan

THOMSON REUTERS
·
Apr 03

Analysts’ Top Healthcare Picks: Serina Therapeutics (SER), Pharma Mar SA (PHMMF)

TIPRANKS
·
Mar 27

Serina Therapeutics, Inc FY Revenue USD 130 Thousand

THOMSON REUTERS
·
Mar 26

Serina Therapeutics FY2025 net loss widens 71.46% to $(19.2) million; revenue rises more than doubled to $130,000

Reuters
·
Mar 26

Serina Therapeutics Chief Scientific Officer Moreadith Randall disposes of USD 18,568 in common shares

Reuters
·
Mar 25

Serina Therapeutics CEO to present at the 38th Annual Roth Conference

Reuters
·
Mar 24

BRIEF-Serina Therapeutics Inc - Appoints Greg Bailey As Co-Chairman Of Board - SEC Filing

Reuters
·
Mar 24

Serina Therapeutics Inc - Appoints Greg Bailey as Co-Chairman of Board - SEC Filing

THOMSON REUTERS
·
Mar 24

Serina Therapeutics raises up to USD 30 million to advance SER-252 registrational trial in advanced Parkinson’s disease

Reuters
·
Mar 24

Serina Therapeutics CSO Randall Moreadith disposed of USD 97,500 in common shares

Reuters
·
Mar 21

Stock Market Today: S&P 500, Dow Futures Down Ahead Of 'Triple Witching' As Iran Warns Of 'Zero Restraint'—FedEx, Super Micro Computer In Focus

Benzinga Earnings
·
Mar 20

Top Midday Gainers

MT Newswires Live
·
Mar 20

Gold Tumbles Over 6%; Accenture Earnings Top Views

Benzinga Earnings
·
Mar 20

Serina Therapeutics names Greg Bailey co-chairman

TIPRANKS
·
Mar 19

Serina Therapeutics announces USD 15 million private placement of common stock and pre-funded warrants

Reuters
·
Mar 19

Serina Therapeutics Advances SER-252 Parkinson’s Trial, Marking a Key Early Milestone for Investors

TIPRANKS
·
Mar 04

Serina Therapeutics: Blinded Evaluation of Safety, Tolerability Data From Cohort 1 & Advancement to Cohort 2 Expected in 3Q 2026

THOMSON REUTERS
·
Feb 25

Serina Therapeutics doses first patient in SER-252 trial

TIPRANKS
·
Feb 25

Serina Therapeutics doses first patient in Phase 1b registrational trial of SER-252 for advanced Parkinson’s disease

Reuters
·
Feb 25